Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet

TOKYO, April 16, 2020 /PRNewswire/ -- Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (generic name: favipiravir), for the novel coronavirus disease (referr...

2020-04-16 23:33 3246

Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19

BEIJING, April 16, 2020 /PRNewswire/ -- A news report by Science and Technology Daily: Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug is quite tough. It is not practic...

2020-04-16 23:05 2284

Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble's Novel Biomarker Discovery Engine

MADISON, Wisconsin and MALMÖ, Sweden, April 16, 2020 /PRNewswire/ -- Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble's powerful and broadly applicable biomarker discovery engine and Svar's strongin ...

2020-04-16 23:00 1686

IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea

PLYMOUTH MEETING, Pennsylvania and SEOUL, South Korea, April 16, 2020 /PRNewswire/ -- The International Vaccine Institute (IVI) announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) has granted$6.9 million funding to INOVIO (NASDAQ:INO) to work with IVI and the Korea Nat...

2020-04-16 18:00 3194

Three Chinese Vaccines against COVID-19 are on the Way

BEIJING, April 16, 2020 /PRNewswire/ -- According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) ofChina, making them the firs...

2020-04-16 11:03 2321

Australia to test COVID-19 vaccine

MELBOURNE, Australia, April 15, 2020 /PRNewswire/ -- The first COVID-19 vaccine to be tested outside of theUSA, and only the third vaccine clinical trial in the world, will be conducted byAustralia's largest Phase 1 clinical trials specialist Nucleus Network. As part of the urgent global race to...

2020-04-15 11:15 1498

Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Li...

2020-04-15 05:55 7659

Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma

SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ -- Antengene announced today that it has dosed the first patient inTaiwan, China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and...

2020-04-14 21:15 1482

Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen"

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic ofChina has purchased 700,000 boxes of Lianhua Qingwen and distribute them to eachChinese embassy. The health packages ...

2020-04-13 22:25 2639

Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...

2020-04-13 21:55 1987

Seegene Receives Health Canada Approval for its COVID-19 Assay

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...

2020-04-13 21:00 2296

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...

2020-04-13 20:00 3344

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility

TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...

2020-04-10 14:00 2237

Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS

GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...

2020-04-09 20:00 3381

World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight

SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...

2020-04-09 15:57 1381

EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries

PROVIDENCE, Rhode Island, April 8, 2020 /PRNewswire/ -- EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with GAIA Vaccine Foundation ("...

2020-04-08 03:57 2466

HOYA/PENTAX Medical Issues Statement Regarding U.S. Department of Justice Settlement

MONTVALE, New Jersey and TOKYO, April 7, 2020 /PRNewswire/ -- HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, "PENTAX" or "the Company"), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on i...

2020-04-07 23:36 3514

Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study

SYDNEY, April 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share positive interim data from its ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most common and most agg...

2020-04-07 20:00 3857

CROMSOURCE Announces Launch of COVID-19 Clinical Trial

VERONA, Italy, 7 April, 2020 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) with its global headquarters inVerona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be pe...

2020-04-07 19:01 2617

INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today

- Up to 40 Healthy Volunteers To Participate at Two Trial Locations - Preclinical Animal Studies Show Promising Immune Responses - Rapid Advancement Possible Through a Global Coalition of Collaborators, Partners, and Funders PLYMOUTH MEETING, Pennsylvania, April 6, 2020 /PRNewswire/ -- INOVIO...

2020-04-06 20:30 3241

1 ... 175 176 177178179 180 181 ... 187